Reading "Accident Case Learning Materials"
Release time:
2023-07-26
The theme of this year's Safety Month is "Everyone talks about safety, everyone will respond to emergencies", which is to let employees understand safety knowledge and be able to deal with situations when dangers occur. The safety management office of the group company specially issued the "learning materials on accident cases", and I learned it in the first place.
"Accident Case Learning Materials" are collected and reported by subordinate enterprises, and then sorted, summarized, reviewed and revised by the Safety Management Office of the Group Company. The learning materials cover 15 accident cases of chemical enterprises, 30 accident cases of cement enterprises and 15 accident cases of general industrial and trade enterprises. These accidents are caused by various factors, including equipment failure, personnel illegal operation, and very few changes in the external environment. After careful study and analysis, I found that nearly 60% of the accidents in 50 cases were related to personnel's illegal operations. The reasons for further subdivision in the illegal operation of personnel: some operators are not high in quality and careless; Not familiar with the operating procedures; The personnel did not analyze the on-site situation before starting up, and the hidden dangers were not eliminated for starting up.
It can be seen that people are one of the key factors in accidents. Therefore, I think the following aspects should be done to ensure safe production.
Improve the comprehensive quality of employees and cultivate the safety concept of employees. The company can regularly invite safety lecturers into the factory to carry out training to improve the comprehensive quality of employees, transmit some new safety ideas that keep pace with the times, and shape a new world outlook and safety outlook for employees. The comprehensive quality of employees is the spiritual outlook of an enterprise. It is not a good thing for employees to have low quality, do things carelessly and often shirk their responsibilities. High-quality employees have a strong sense of responsibility, and the level of operation will be relatively better, which can reduce the probability of some accidents to a certain extent.
Strengthen the familiarity with the operating procedures. After the safety operation procedures were issued, there were not many employees who took the initiative to study and study, and the self-study efficiency was not high. The leaders of the production department regularly organize training on safety operation procedures to let employees know the safety operation procedures well and actively guide the operators to operate strictly according to the production operation procedures. This may greatly reduce the occurrence of operational accidents.
Strengthen the control and familiarity of the startup site before startup. Before starting the machine, the main operator shall carefully check whether the machine and equipment are in good condition, whether the oil is sufficient, and whether the surrounding environment meets the starting conditions. These points are best evaluated and documented. A lot of accidents are because the boot situation is not clear, random boot caused.
Safety has never been a matter for one person. We all need to maintain and cherish it together. (sheng xiaofeng)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page